Francesco Ciccimarra

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

M. Molokhia, G. Trifirò, E. Tacconelli, 2023, BioDrugs.

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

C. Chiamulera, G. Trifirò, A. Vannacci, 2023, Drug Safety.

Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants

S. Crisafulli, Francesco Ciccimarra, Gianluca Trifirò, 2024, Expert opinion on drug metabolism & toxicology.

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

S. Crisafulli, Francesco Ciccimarra, Chiara Bellitto, 2024, Frontiers in Drug Safety and Regulation.

Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature

Francesco Ciccimarra, Gianluca Trifirò, Salvatore Crisafulli, 2024, Toxins.